CDK7-IN-33

Overview

CDK7-IN-33 is an orally active pyrimidine derivative and also a CDK7 kinase inhibitor. CDK7-IN-33 is applicable to the research of cancer , inflammation, cardiovascular diseases, infectious diseases, immune diseases and metabolic diseases.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Signaling Pathways > CDK

Product Information

• Catalog No.: HY-181565
• CAS No.: 2640208-32-6
• Molecular Formula: C21H20F6N6O2
• Molecular Weight: 502.41
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source